It is a trading private limited company based in Thane, Maharashtra, India, established in 2014.
2014 | Thane, Maharashtra, India | ActiveTeq Pharmaceuticals Private Limited, a active private limited company, was established on 15 July 2014 in Thane, Maharashtra, India. Engaging in other wholesale within the trade sector, it holds CIN: U74999MH2014PTC256076. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a active non-compliant status. Its leadership includes Ajeet Kumar Rai (Additional Director), Ramkinkar Ramdular Rai (Director). Past directors included Manoj Balbir Sodha, Arjun Dipnarayan Pandey. Its latest AGM occurred on 29 September 2018, with the balance sheet filed on 31 March 2018. It is based at Shop No. 7, Ostwal Orchid Bldg. No. 45 Prathmesh(Heritage),Beverly Park, Mira R, Oad (East), Thane, Maharashtra, 401107.
U74999MH2014PTC256076
256076
15 July 2014
₹0.10 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Teq Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ajeet Kumar Rai | Additional Director | 12 Mar 2020 | Current |
| Ramkinkar Ramdular Rai | Director | 15 Jul 2014 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 30 May 2016 | Past |
| Pramod Abcsdd | Director | 12 Mar 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Teq Pharmaceuticals Private Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 13.4% increase. The company also saw a substantial fall in profitability, with a 2961.38% decrease in profit. The company's net worth observed a substantial decline by a decrease of 384.91%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Teq Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Teq Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Teq Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Teq Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Ajeet Kumar Rai was appointed as a Additional Director was appointed as a Additional Director on 12 Mar 2020 & has been associated with this company since 5 years 9 months . was recorded as a recent event.
Progress on Teq Pharmaceuticals Private Limited last Annual general meeting of members was held on 29 Sep 2018 as per latest MCA records. was documented.
Teq Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2018 with Roc Mumbai. was recorded as a recent event.
Ramkinkar Ramdular Rai was appointed as a Director was appointed as a Director on 15 Jul 2014 & has been associated with this company since 11 years 5 months . was recorded as a recent event.
Progress on Teq Pharmaceuticals Private Limited was registered on 15 Jul 2014 with Roc Mumbai & aged 11 years 5 months as per MCA records. was documented.
The CIN of Teq Pharmaceuticals Private Limited is U74999MH2014PTC256076.
Teq Pharmaceuticals Private Limited is headquartered at Shop No. 7, Ostwal Orchid Bldg. No. 45 Prathmesh(Heritage),Beverly Park, Mira R, Oad (East), Thane, Maharashtra, 401107.
Teq Pharmaceuticals Private Limited was incorporated on 15 July 2014.
The current directors of Teq Pharmaceuticals Private Limited are
The primary industry of Teq Pharmaceuticals Private Limited is Trade.
Teq Pharmaceuticals Private Limited is unlisted.
The authorized capital of Teq Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Teq Pharmaceuticals Private Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX